ROSSITTO, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 4.649
AS - Asia 2.394
EU - Europa 1.427
AF - Africa 574
SA - Sud America 505
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 26
Totale 9.637
Nazione #
US - Stati Uniti d'America 4.315
SG - Singapore 851
CN - Cina 387
HK - Hong Kong 355
BR - Brasile 304
IT - Italia 267
VN - Vietnam 162
DE - Germania 127
FI - Finlandia 100
SE - Svezia 96
PL - Polonia 95
GB - Regno Unito 94
RU - Federazione Russa 66
IN - India 60
NL - Olanda 58
FR - Francia 53
AR - Argentina 38
MX - Messico 34
UG - Uganda 34
CA - Canada 33
IQ - Iraq 32
EC - Ecuador 31
UA - Ucraina 31
ES - Italia 29
UZ - Uzbekistan 28
ID - Indonesia 27
PA - Panama 27
JP - Giappone 26
CY - Cipro 24
IE - Irlanda 24
JM - Giamaica 24
MY - Malesia 24
DZ - Algeria 23
PK - Pakistan 23
PY - Paraguay 23
TR - Turchia 23
BJ - Benin 22
KR - Corea 22
PH - Filippine 22
PT - Portogallo 22
AU - Australia 21
EE - Estonia 21
MA - Marocco 21
NI - Nicaragua 21
ZA - Sudafrica 21
AE - Emirati Arabi Uniti 20
BY - Bielorussia 20
LB - Libano 20
SA - Arabia Saudita 20
BZ - Belize 19
CO - Colombia 19
JO - Giordania 19
PE - Perù 19
RS - Serbia 19
AZ - Azerbaigian 18
BA - Bosnia-Erzegovina 18
BE - Belgio 18
HU - Ungheria 18
MD - Moldavia 18
AT - Austria 17
BF - Burkina Faso 17
CV - Capo Verde 17
GM - Gambi 17
LY - Libia 17
PR - Porto Rico 17
TT - Trinidad e Tobago 17
BO - Bolivia 16
CH - Svizzera 16
CL - Cile 16
GE - Georgia 16
KE - Kenya 16
KG - Kirghizistan 16
LC - Santa Lucia 16
MN - Mongolia 16
NP - Nepal 16
SK - Slovacchia (Repubblica Slovacca) 16
CU - Cuba 15
CW - ???statistics.table.value.countryCode.CW??? 15
GN - Guinea 15
IL - Israele 15
MK - Macedonia 15
MR - Mauritania 15
MZ - Mozambico 15
NO - Norvegia 15
TH - Thailandia 15
TN - Tunisia 15
AO - Angola 14
CI - Costa d'Avorio 14
CZ - Repubblica Ceca 14
GH - Ghana 14
HN - Honduras 14
ME - Montenegro 14
MG - Madagascar 14
MW - Malawi 14
TW - Taiwan 14
UY - Uruguay 14
ZM - Zambia 14
BG - Bulgaria 13
CD - Congo 13
DO - Repubblica Dominicana 13
Totale 9.028
Città #
Fairfield 575
Ashburn 512
Singapore 486
Hong Kong 346
Woodbridge 288
Ann Arbor 248
Chandler 246
Houston 244
Seattle 186
Cambridge 172
Wilmington 154
Beijing 153
Los Angeles 101
Santa Clara 98
Boardman 92
Chicago 84
Padova 79
New York 69
Bytom 63
San Diego 60
Medford 52
Princeton 49
Ho Chi Minh City 48
Helsinki 45
Munich 44
Salt Lake City 38
Buffalo 35
Roxbury 35
Kampala 33
Des Moines 32
São Paulo 28
Hanoi 26
Nanjing 26
Panama City 26
Tashkent 23
Hefei 22
Milan 21
Cotonou 20
Dublin 20
Managua 20
Dong Ket 19
Tampa 19
Amman 17
Warsaw 17
Chennai 16
Nuremberg 16
Padua 16
Ulan Bator 16
Castries 15
Conakry 15
Elk Grove Village 15
Havana 15
Kingston 15
Lappeenranta 15
London 15
Baghdad 14
Brooklyn 14
Guangzhou 14
Limassol 14
Maputo 14
Nairobi 14
Ouagadougou 14
Podgorica 14
Redondo Beach 14
Rio de Janeiro 14
Seoul 14
Tallinn 14
Abidjan 13
Baku 13
Kuala Lumpur 13
Lusaka 13
Minsk 13
Montevideo 13
Montreal 13
Nouakchott 13
Turku 13
Accra 12
Antananarivo 12
Bamako 12
Harare 12
Jacksonville 12
Phnom Penh 12
Praia 12
Tbilisi 12
Tokyo 12
Willemstad 12
Amsterdam 11
Bishkek 11
Chisinau 11
Lima 11
Stockholm 11
Tripoli 11
Andorra la Vella 10
Asunción 10
Boston 10
Bridgetown 10
Casablanca 10
Denver 10
Dulles 10
Istanbul 10
Totale 5.691
Nome #
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study 283
Lymphatic vessels and the renin-angiotensin-system 267
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 248
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 218
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 205
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 204
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 201
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension 195
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 193
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 188
Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease. 185
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 182
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 178
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 175
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 175
'Essential' arterial hypertension: time for a paradigm change 173
Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade 169
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 164
Management of hypertensive emergencies: a practical approach 164
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 163
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 163
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 161
Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution 161
Oral burning with dysphagia and weight loss 158
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 158
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 157
Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism 154
Elevation of Angiotensin-II Type-1-Receptor Autoantibodies Titer in Primary Aldosteronism as a Result of Aldosterone-Producing Adenoma. 150
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 150
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 145
Modern Management of Hypertensive Emergencies 144
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 143
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 141
Clinical Outcomes of 1625 Patients with Primary Aldosteronism Subtyped with Adrenal Vein Sampling 141
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 133
Cell-mediated autoimmune mechanisms involved in the pathogenesis of primary aldosteronism. 129
Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. 127
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 126
Primary Aldosteronism and Drug Resistant Hypertension: A "Chicken-Egg" Story 125
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 124
Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large Multiethnic International Study 120
A Worrying and Puzzling Case of Hypertension Presenting to the Emergency Department 115
Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism 115
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study 114
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 108
Tissue sodium excess is not hypertonic and reflects extracellular volume expansion 107
Tangram of Sodium and Fluid Balance 106
Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction 104
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 104
Skin-specific mechanisms of body fluid regulation in hypertension 99
Q: Should alpha-blockers ever be used as antihypertensive drugs? 97
Clinical Management of Primary Aldosteronism: An Update 95
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 92
Sodium, Interstitium, Lymphatics and Hypertension-A Tale of Hydraulics 91
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism 90
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling 90
Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review 86
Coronary sinus diameter to estimate congestion and predict survival 86
Antibodies to malondialdehyde oxidized LDL predict cardiovascular events during long-term follow-up in high risk coronary artery disease patients. 84
Haemodynamic assessment in hypertension: the soloists and the orchestra 84
Does Excess Tissue Sodium Storage Regulate Blood Pressure? 83
Ipertensione e surrene 81
Dr Giacomo Rossitto interviews Professor Rhian Touyz, on the translational applications of vascular smooth muscle cell biology in cardiovascular disease 80
Much Ado about N⋯ atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localized oedema 77
Aldosterone and Cardiovascular Damage: a New Lesson From an Old Study 74
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 73
Pathophysiology of Hypertension 73
The Lymphatic System 72
Antihypertensive Drugs and Vascular Health 69
Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism" 67
Response to the letter regarding the hypothesis paper “Much ado about N . . . Atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localised oedema” 62
Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats 61
Of Snails, Earthworms, and Men: Insights into Strategies to Preserve Water 52
Mechanisms of sodium-mediated injury in cardiovascular disease: old play, new scripts 41
Totale 9.772
Categoria #
all - tutte 30.992
article - articoli 29.892
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.100
Totale 61.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021772 0 0 0 0 0 11 141 50 72 245 44 209
2021/2022707 24 45 38 62 62 93 37 52 48 54 34 158
2022/2023570 114 46 26 44 86 58 7 44 80 27 26 12
2023/2024345 16 40 42 32 17 41 23 15 21 13 33 52
2024/20251.834 12 148 96 43 185 43 166 161 116 130 278 456
2025/20264.254 408 512 993 1.358 938 45 0 0 0 0 0 0
Totale 9.772